Nutex Health, INC. 8-K Filing
Ticker: NUTX · Form: 8-K · Filed: Nov 24, 2025 · CIK: 1479681
| Field | Detail |
|---|---|
| Company | Nutex Health, INC. (NUTX) |
| Form Type | 8-K |
| Filed Date | Nov 24, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Nutex Health, INC. (ticker: NUTX) to the SEC on Nov 24, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ange on which registered Common Stock, $0.001 par value NUTX The NASDAQ Stock Marke).
How long is this filing?
Nutex Health, INC.'s 8-K filing is 2 pages with approximately 453 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 453 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-11-24 16:52:11
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value NUTX The NASDAQ Stock Marke
Filing Documents
- nutx-20251124.htm (8-K) — 27KB
- nutexconsentforfilingwithn.htm (EX-23.1) — 2KB
- 0001628280-25-053849.txt ( ) — 146KB
- nutx-20251124.xsd (EX-101.SCH) — 2KB
- nutx-20251124_lab.xml (EX-101.LAB) — 22KB
- nutx-20251124_pre.xml (EX-101.PRE) — 13KB
- nutx-20251124_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. Included as Exhibit 23.1 is an auditors' consent to the incorporation by reference into certain previously filed registration statements of their report relating to the consolidated balance sheet of Nutex Health Inc. (the "Company") as of December 31, 2023, the related consolidated statements of operations, changes in equity and cash flows for each of the two years in the period ended December 31, 2023, and the related notes, which report is included in the Company's Form 10-K/A filed on November 18, 2025.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 23.1 Consent of Marcum LLP SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Date: November 24, 2025 NUTEX HEALTH INC. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer